Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

Thermo Fisher expands its Gibco Bacto CD portfolio with new formulations aimed at boosting E. coli-based plasmid DNA and protein production efficiency.

In early December 2025, Twist Bioscience launched research-grade Plasmid DNA Preps with animal origin-free and endotoxin-free options tailored to stringent preclinical study requirements. This move ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidenceWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world ...

A postdoctoral researcher at Indiana University has been federally charged after allegedly using women’s underwear shipments ...